Endevica Bio logo
VerifiedBiotechnology Research· Founded 2009

Endevica Bio

Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 2 Clinical trials in the US are underway.

7-day free trial · no credit card

HeadquartersColumbia, United StatesEmployees21(11 to 50)Founded year2009Websiteendevicabio.comLinkedIn profileLinkedIn

Verified contacts

19

available on Kipplo

LinkedIn employees

21

11 to 50 range

Open roles

no listings

Distinct roles

13

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 19 verified contacts at Endevica Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

19 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Endevica Bio

13 distinct titles indexed · top 10 shown.

  • 3scientific lead
  • 3senior scientist
  • 1ceo and executive chairman
  • 1chief medical officer
  • 1director, cmc development
  • 1head of cmc
  • 1head of computational chemistry
  • 1head of preclincial studies
  • 1lead clinical scientist
  • 1med-iq
  • +3more titles

Sign up to unlock all 19 contacts at Endevica Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 19 verified contacts at Endevica Bio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Endevica Bio | Kipplo Discover